Company / Operating Cash Flow per Share
Sana Biotechnology, Inc. Operating Cash Flow per Share History
FY2019-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$0.97
FY2024
5-year range
-$10.60 / -$0.97
FY2020-FY2024
Trend
+25.9%
vs FY2023
Sector context
#114 of 212
Health Care
What the data says
At $-0.97, Sana Biotechnology, Inc.'s operating cash flow per share ranks #114 of 212 in the Health Care sector. Improved from $-1.54 to $-0.97 over the past 2 years.
Based on SEC 10-K filings.
-0.97 in FY2024.
Improved from $-1.54 to $-0.97 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#114 of 212 in Health CareTop 54% of 212This company -$0.97 Sector average -$14.72
▼
+93.4% above sector average
Key checks
Key Insights
- In FY2024, operating cash flow per share increased 25.9% year-over-year.
- Ranks #114 out of 212 companies in the Health Care sector.
- Lowest operating cash flow per share in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.11 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$0.97 | +25.9% |
| FY2023 | -$1.30 | +15.4% |
| FY2022 | -$1.54 | -2.1% |
| FY2021 | -$1.51 | +85.8% |
| FY2020 | -$10.60 | +39.2% |
| FY2019 | -$17.44 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026